Detalles de la búsqueda
1.
Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study.
Invest New Drugs
; 30(2): 681-7, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20830502
2.
A Phase II, open-label, randomised study to assess the efficacy and safety of the MEK1/2 inhibitor AZD6244 (ARRY-142886) versus capecitabine monotherapy in patients with colorectal cancer who have failed one or two prior chemotherapeutic regimens.
Invest New Drugs
; 29(5): 1021-8, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20127139
3.
A randomized, double-blind, placebo-controlled phase II study of vandetanib plus docetaxel/prednisolone in patients with hormone-refractory prostate cancer.
Cancer Biother Radiopharm
; 24(2): 175-80, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19409038
Resultados
1 -
3
de 3
1
Próxima >
>>